Hrt Financial LP Prelude Therapeutics Inc Transaction History

Hrt Financial LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$4.58 - $7.34 $101,561 - $162,764	22,175 New	22,175 $126,000
Q1 2022 May 16, 2022	SELL	$6.9 - $13.22 $788,318 - $1.51 Million	-114,249 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$11.89 - $31.74 $1.17 Million - $3.13 Million	98,690 Added 634.3%	114,249 $1.42 Million
Q3 2021 Nov 15, 2021	BUY	$25.78 - $38.65 $401,111 - $601,355	15,559 New	15,559 $486,000

35.7M

500

300

Ticker PRLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,369,200
Market Cap $34.6M
Description
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.